Blackstone Inc
UTHR icon

Blackstone Inc’s United Therapeutics UTHR Stock Holding History

Blackstone Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
+1,813
New +$1.02M ﹤0.01% 258
2019
Q2 		– Sell
-55,813
Closed -$6.55M – 107
2019
Q1 		$6.55M Buy
+55,813
New +$6.5M 0.03% 49

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Blackstone Inc's UTHR Position: Q2 2026 in Review

Blackstone Inc opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,813 shares worth $982K. The stake represents ﹤0.01% of the portfolio and ranks #258 among its holdings. This is a return to the name: Blackstone Inc previously reported a position in UTHR as recently as Q1 2019.

Blackstone Inc first reported a position in UTHR in Q1 2019 and has held it in 2 quarters since. The position peaked at $6.55M in Q1 2019. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Blackstone Inc held 1,813 shares of United Therapeutics worth $982K as of Q2 2026.
  • United Therapeutics was a new Blackstone Inc position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #258 holding.
  • Blackstone Inc first reported a position in United Therapeutics in Q1 2019 and has held it in 2 quarters since.
  • Blackstone Inc's United Therapeutics position peaked at $6.55M in Q1 2019.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.